Oncotarget

Research Papers:

Endothelial integrin α3β1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macromolecular signaling complex formation at the endothelial cell membrane

Olga V. Glinskii, Feng Li, Landon S. Wilson, Stephen Barnes, Kate Rittenhouse-Olson, Joseph J. Barchi Jr, Kenneth J. Pienta & Vladislav V. Glinsky _

PDF  |  HTML  |  Order a Reprint

Oncotarget. 2014; 5:1382-1389. https://doi.org/10.18632/oncotarget.1837

Metrics: PDF 1350 views  |   HTML 1390 views  |   ?  


Abstract

Olga V. Glinskii1,2, Feng Li1,2, Landon S. Wilson3, Stephen Barnes3, Kate Rittenhouse-Olson4, Joseph J. Barchi, Jr.5, Kenneth J. Pienta6, Vladislav V. Glinsky1,2

1 Research Service, Harry S. Truman Memorial Veterans Hospital, Columbia, MO

2 Department of Pathology and Anatomical Sciences and the Department of Medical Pharmacology and Physiology, University of Missouri School of Medicine, Columbia, MO

3 Department of Pharmacology and Toxicology and Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham, Birmingham, AL

4 Department of Biotechnical and Clinical Laboratory Sciences and the Department of Microbiology, University of Buffalo, Buffalo, NY

5 Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick National Laboratory for Cancer Research, Frederick, MD

6 Department of Urology, The James Buchanan Brady Urological Institute, Departments of Oncology and Pharmacology and Molecular Sciences, The Johns Hopkins School of Medicine, Baltimore, MD

Correspondence:

Vladislav V. Glinsky, email:

Keywords: tumor metastasis, adhesion, Thomsen-Friedenreich antigen, galectin, integrin

Received: February 10, 2014 Accepted: March 19, 2014 Published: March 20, 2014

Abstract

Blood borne metastatic tumor cell adhesion to endothelial cells constitutes a critical rate-limiting step in hematogenous cancer metastasis. Interactions between cancer associated carbohydrate Thomsen-Friedenreich antigen (TF-Ag) and endothelium-expressed galectin-3 (Gal-3) have been identified as the leading molecular mechanism initiating tumor/endothelial cell adhesion in several types of cancer. However, it is unknown how these rather weak and transient carbohydrate/lectin mediated interactions are stabilized. Here, using Western blot and LC tandem mass spectrometry analyses of pull-downs utilizing TF-Ag loaded gold nanoparticles, we identified Gal-3, endothelial integrin α3β1, Src kinase, as well as 5 additional molecules mapping onto focal adhesion pathway as parts of the macromolecular complexes formed at the endothelial cell membranes downstream of TF-Ag/Gal-3 interactions. In a modified parallel flow chamber assay, inhibiting α3β1 integrin greatly reduced the strength of tumor/endothelial cell interactions without affecting the initial cancer cell adhesion. Further, the macromolecular complex induced by TF-Ag/Gal-3/α3β1 interactions activates Src kinase, p38, and ERK1/2, pathways in endothelial cells in a time- and α3β1-dependent manner. We conclude that, following the initial metastatic cell attachment to endothelial cells mediated by TF-Ag/Gal-3 interactions, endothelial integrin α3β1 stabilizes tumor/endothelial cell adhesion and induces the formation of macromolecular signaling complex activating several major signaling pathways in endothelial cells.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 1837